Guideline for the diagnosis and management of vitiligo

British Journal of Dermatology

Volumn 159, Issue 5, 2008, Pages 1051-1076

  Gawkrodger, D J ^a,b   Ormerod, A D ^b   Shaw, L ^b   Mauri Sole, I ^b   Whitton, M E ^c,d   Watts, M J ^b   Anstey, A V ^b   Ingham, J ^e   Young, K ^e  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b BRITISH ASSOCIATION OF DERMATOLOGISTS   (United Kingdom)

^c Vitiligo Society   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

Diagnosis; Guidelines; Treatment; Vitiligo

Indexed keywords

BETAMETHASONE; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CLOBETASOL; CORTICOSTEROID; COSMETIC; CYCLOSPORIN; FLUTICASONE; HYDROQUINONE; KHELLIN; MEQUINOL; MONOBENZONE; PIMECROLIMUS; PSORALEN; STEROID; SUNSCREEN; TACALCITOL; TACROLIMUS; TRIAMCINOLONE; VITAMIN D DERIVATIVE;

ACNE; ALGORITHM; CLINICAL TRIAL; COGNITIVE THERAPY; CONTACT DERMATITIS; DEPIGMENTATION; HUMAN; HYPERTRICHOSIS; OCHRONOSIS; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN IRRITATION; SKIN TRANSPLANTATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO;

ADULT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PSYCHOTHERAPY; QUALITY OF LIFE; ULTRAVIOLET THERAPY; VITILIGO;

EID: 54249084098     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08881.x     Document Type: Review

References (125)

1. Nordlund JJ, Majumder PP. Recent investigations on vitiligo vulgaris. Dermatol Clin 1997 15 : 69 78.
2. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999 72 : 385 96.
3. Mason CP, Gawkrodger DJ. Vitiligo presentation in adults. Clin Exp Dermatol 2005 30 : 344 5.
4. Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev 2006 1 : CD003263.
5. Taieb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007 20 : 27 35.
6. Fulton JE Jr. Utilizing the ultraviolet (UV detect) camera to enhance the appearance of photodamage and other skin conditions. Dermatol Surg 1997 23 : 163 9.
7. Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 1994 55 : 981 90.
8. Howitz J, Schwartz M, Thomsen K. Prevalence of vitiligo. Arch Dermatol 1977 113 : 47 52.
9. Chun WH, Hann S-H. The progression of nonsegmental vitiligo: clinical analysis of 318 patients. Int J Dermatol 1997 36 : 908 10.
10. Barona MI, Arrunategui A, Falabella R, Alzatwe A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol 1995 33 : 621 5.
11. Firooz A, Bouzari N, Fallah N et al. What patients with vitiligo believe about their condition. Int J Dermatol 2004 43 : 811 14.
12. McMichael AJ, Shaw K, Cayce K et al. Facial blemishes and QoL. J Cosmet Dermatol 2004 17 : 107 13.
13. Mattoo SK, Handa S, Kaur L et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002 16 : 573 8.
14. Parsad D, Pandhi R, Dogra S et al. DLQI score in vitiligo and its impact on treatment outcome. Br J Dermatol 2003 148 : 373 4.
15. Ongenae K, Dierckxsens L, Brochez L et al. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005 210 : 279 85.
16. van Geel NAC, Ongenae K, Vander Haeghen YMSJ, Naeyaert JM. Autologous transplantation techniques for vitiligo: how to evaluate treatment outcome. Eur J Dermatol 2004 14 : 46 51.
17. Porter JP, Beuf AH, Nordlund JJ, Lerner AB. Personal responses of patients to vitiligo: the importance of the patient-physician interaction. Arch Dermatol 1978 114 : 1384 5.
18. Agarwal S, Ramam M, Sharma VK et al. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo. Br J Dermatol 2005 153 : 163 6.
19. Hartmann A, Lurz C, Hamm H et al. Narrow-band UVB 311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol 2005 44 : 736 42.
20. Ongenae K, van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005 152 : 1165 72.
21. Aghaei S, Sodaifi M, Jafari P et al. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004 4 : 8.
22. Njoo MD, Boss JD, Westerhof W. Treatment of generalised vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000 42 : 245 53.
23. Kent GG, Al'Abadie MSK. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 1996 35 : 895 8.
24. Kent GG, Al'Abadie MSK. Factors affecting responses on DLQI items amongst vitiligo sufferers. Clin Exp Dermatol 1996 21 : 330 3.
25. Kent GG. Correlates of perceived stigma in vitiligo. Psychol Health 1999 14 : 241 51.
26. Stangier U, Gieler U, Ehlers A. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess 2003 15 : 532 49.
27. Sampogna F, Picardi A, Chren M-M et al. Association between poorer QoL and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004 66 : 620 4.
28. Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol 2001 28 : 419 23.
29. Porter JR, Beuf AH. Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J Health Soc Behav 1991 32 : 192 204.
30. Papadopoulos L, Bor R, Walker C et al. Different shades of meaning: illness beliefs among vitiligo sufferers. Psychology 2002 7 : 425 33.
31. Hamzavi I, Shapiro J. Parametric modelling of narrow band UV-B phototherapy for vitiligo using a novel quantitative tool. Arch Dermatol 2004 140 : 677 83.
32. Lepe V, Moncada B, Castanedo-Cazares JP et al. A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003 139 : 581 5.
33. Clayton R. A double-blind trial of 0.05% clobetasol propionate in the treatment of vitiligo. Br J Dermatol 1977 96 : 71 3.
34. Kandil E. Treatment of vitiligo with 0.1 per cent betamethasone 17-valerate in isopropyl alcohol - a double-blind trial. Br J Dermatol 1974 91 : 457 60.
35. Westerhof W, Nieuweboer-Krobotova L, Mulder PGH, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. Arch Dermatol 1999 135 : 1061 6.
36. Coskun B, Saral Y, Turgut D. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo. Eur J Dermatol 2005 15 : 88 91.
37. Kumaran MS, Kaur I, Kumar B. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol 2006 20 : 269 73.
38. Khalid M, Mujtaba G, Haroon TS. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo. Int J Dermatol 1995 34 : 203 5.
39. Chiaverini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol 2002 16 : 137 8.
40. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001 145 : 476 9.
41. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet-A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001 145 : 472 5.
42. Baysal V, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol 2003 17 : 299 302.
43. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998 197 : 167 70.
44. Cherif F, Azaiz MI, Ben Hamida A et al. Calcipotriol and PUVA as treatment for vitiligo. Dermatol Online J 2003 9 : 4.
45. Boone B, Ongenae K, van Geel N et al. Topical pimecrolimus in the treatment of vitiligo. Eur J Dermatol 2007 17 : 55 61.
46. Passeron T, Ostovari N, Zakaria W et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 2004 140 : 1065 9.
47. Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg 2004 30 : 130 5.
48. Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol 2000 42 : 760 9.
49. Mosher DB, Parrish JA, Fitzpatrick TB. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol 1977 97 : 669 79.
50. Shaffrali F, Gawkrodger D. Management of vitiligo. Clin Exp Dermatol 2000 25 : 575 9.
51. Bolognia JL, Lapia K, Somma S. Depigmentation therapy. Dermatol Ther 2001 14 : 29 34.
52. Le Poole C, Boissy RE. Vitiligo. Semin Cutan Med Surg 1997 16 : 3 14.
53. Kenney JA Jr., Grimes PE. How we treat vitiligo. Cutis 1983 32 : 347 8.
54. Antoniou C, Katsambas A. Guidelines for the treatment of vitiligo. Drugs 1992 43 : 490 8.
55. Nordlund JJ, Grimes PE, Ortonne JP. The safety of hydroquinone. J Eur Acad Dermatol Venereol 2006 20 : 781 7.
56. Kooyers TJ, Westerhof W. Toxicology and health risks of hydroquinone in skin lightening formulations. J Eur Acad Dermatol Venereol 2006 20 : 777 80.
57. Yones SS, Palmer RA, Garibaldinos TM, Hawk JLM. Randomised double-blind trial of treatment of vitiligo. Efficacy of psoralen-UVA vs. narrowband-UVB therapy. Arch Dermatol 2007 143 : 578 84.
58. Menchini G, Tsoureli-Nikita E, Hercogova J. Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. J Eur Acad Dermatol Venereol 2003 17 : 171 7.
59. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. topical psoralen plus UVA. Arch Dermatol 1997 133 : 1525 8.
60. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002 46 : 727 31.
61. Hofer A, Hassan AS, Legat FJ et al. The efficacy of excimer laser (308 nm) for vitiligo at different body sites. J Eur Acad Dermatol Venereol 2006 20 : 558 64.
62. Hong SB, Park HH, Lee MH. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. J Korean Med Sci 2005 20 : 273 8.
63. El Mofty AM. A preliminary clinical report on the treatment of leucoderma with Ammi majus Linn. J Egypt Med Assoc 1948 31 : 651 65.
64. Pathak MA. Mechanisms of psoralen photosensitization reactions. Natl Cancer Inst Monogr 1984 66 : 41 6.
65. Sehgal VN. A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo. Int J Dermatol 1975 14 : 205 8.
66. Bhatnagar A, Kanwar AJ, Parsad D. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study. J Eur Acad Dermatol Venereol 2007 21 : 638 42.
67. Abdel-Fattah A, Aboul-Enein MN, Wassel GM, El-Menshawi BS. An approach to treatment of vitiligo by khellin. Dermatologica 1982 165 : 136 40.
68. Procaccini EM, Riccio G, Montfrecola G. Ineffectiveness of topical khellin in photochemotherapy of vitiligo. J Dermatolog Treat 1995 6 : 117 20.
69. Orecchia G, Perfetti L. Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 1992 184 : 120 3.
70. Orecchia G, Sangalli ME, Gazzaniga A, Giordano F. Topical photochemotherapy of vitiligo with new khellin formulation: preliminary clinical results. J Dermatolog Treat 1998 9 : 65 9.
71. Valkova S, Trashlieva M, Christova P. Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol 2004 29 : 180 4.
72. Harrist TJ, Pathak MA, Mosher DB, Fitzpatrick TB. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. Natl Cancer Inst Monogr 1984 66 : 191 6.
73. Wildfang IL, Jacobsen FK, Thestrup-Pedersen K. PUVA treatment of vitiligo. A retrospective study of 59 patients. Acta Derm Venereol (Stockh) 1992 72 : 305 6.
74. Chuan MT, Tsai YJ, Wu MC. Effectiveness of psoralen photochemotherapy for vitiligo. J Formos Med Assoc 1999 98 : 335 40.
75. Westerhof W, Schallreuter KU. PUVA for vitiligo and skin cancer. Clin Exp Dermatol 1996 22 : 54.
76. Halder RM, Battle EF, Smith EM. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol 1995 131 : 734 5.
77. Buckley DA, Rogers S. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 1996 21 : 43 5.
78. Takeda H, Mitsuhashi Y, Kondo S. Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy. J Am Acad Dermatol 1998 38 : 268 70.
79. Abdel Naser MB, Wollina U, El Okby M, El Shiemy S. Psoralen plus ultraviolet-A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin. Clin Exp Dermatol 2004 29 : 380 2.
80. Park HS, Lee YS, Chun DK. Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy. J Eur Acad Dermatol Venereol 2003 17 : 578 80.
81. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988 91 : 120 4.
82. Ada S, Sahin S, Boztepe G et al. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalised vitiligo. Photodermatol Photoimmunol Photomed 2005 21 : 79 83.
83. Goktas EO, Aydin F, Senturk N et al. Combination of narrow-band UVB and topical calcipotriol for the treatment of vitiligo. J Eur Acad Dermatol Venereol 2006 20 : 553 7.
84. Leone G, Pacifico P, Lacovelli P et al. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Clin Exp Dermatol 2006 31 : 200 5.
85. Kullavanijaya P, Lim HW. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2004 20 : 248 51.
86. Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol (Stockh) 2002 82 : 369 72. Erratum in: Acta Derm Venereol (Stockh) 2002; 82: 485.
87. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 1995 190 : 223 9.
88. Schallreuter KU, Moore J, Behrens-Williams S et al. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002 41 : 482 7.
89. Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 2003 28 : 285 7.
90. Banerjee K, Barbhuiya J, Ghosh A et al. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patient. Indian J Dermatol Venereol Leprol 2003 69 : 135 7.
91. Seiter S, Ugurel S, Tilgen W, Reinhold U. Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo. Int J Dermatol 2000 39 : 624 7.
92. Kim SM, Lee HS, Hann SK. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Int J Dermatol 1999 38 : 546 50.
93. Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol 1993 32 : 753 7.
94. Schulpis CH, Antoniou C, Michas T, Strarigos J. Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediatr Dermatol 1989 6 : 332 5.
95. Hernandez Perez E. Vitiligo treated with ACTH. Int J Dermatol 1979 18 : 578 9.
96. Imamura S, Tagami H. Treatment of vitiligo with oral corticosteroids. Dermatologica 1976 153 : 179 85.
97. Pasricha JS, Khera V. Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol 1994 33 : 584 7.
98. Orecchia G, Perfetti L, Borghini F, Malagoli P. Phenylalanine in the treatment of vitiligo. Ann Ital Dermatol Clin Sper 1992 46 : 143 6.
99. Don P, Iuga A, Dacko A, Hardick K. Treatment of vitiligo with broadband ultraviolet B and vitamins. Int J Dermatol 2006 45 : 63 5.
100. Mulekar SV. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation. Dermatol Surg 2006 32 : 536 41.
101. Radmanesh M, Saedi K. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. J Dermatolog Treat 2006 17 : 151 3.
102. Handa S, Pandhi R, Kaur I. Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients. J Dermatol 2001 28 : 461 6.
103. Juhlin L, Olsson MJ. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol (Stockh) 1997 77 : 460 2.
104. Al Khawajah MM. The failure of l-phenylalanine and UVA in the treatment of vitiligo. J Dermatolog Treat 1996 7 : 181 2.
105. Salafia A. Vitiligo. Successful treatment with dapsone. Chron Dermatol 1995 5 : 171 88.
106. Patel IK, Vora NS, Dave JN et al. Comparative study of various drug regimens in vitiligo. Indian J Dermatol Venereol Leprol 1993 59 : 247 50.
107. Farah FS, Kurban AK, Charglassian HT. The treatment of vitiligo with psoralens and triamcinolone by mouth. Br J Dermatol 1967 79 : 89 91.
108. Radakovic-Fijan S, Fürnsinn-Friedl AM, Hönigsmann H, Tanew A. Oral dexamethasone pulse treatment for vitiligo. J Am Acad Dermatol 2001 44 : 814 17.
109. Vasistha LK, Singh G. Vitiligo and intralesional steroids. Indian J Med Res 1979 69 : 308 11.
110. Njoo MD, Westerhoff W, Bos JD, Bossuyt PM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol 1998 134 : 1543 9.
111. Barman KD, Khaitan BK, Verma K. A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo. Dermatol Surg 2004 30 : 49 53.
112. Khandpur S, Sharma VK, Manchandra Y. Comparison of minipunch grafting versus split skin grafting in chronic stable vitiligo. Dermatol Surg 2005 31 : 436 41.
113. Ozdemir M, Cetinkale O, Wolf R et al. Comparison of two surgical approaches for treating vitiligo - a preliminary study. Int J Dermatol 2002 41 : 135 8.
114. Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion and type of disease on outcome. J Am Acad Dermatol 2003 49 : 99 104.
115. Kim HY, Kang KY. Epidermal grafts for the treatment of stable and progressive vitiligo. J Am Acad Dermatol 1999 40 : 412 17.
116. van Geel NA, Ongenae K, De Mil M et al. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Arch Dermatol 2004 140 : 1203 8.
117. Pianigiani E, Risulo M, Andreassi A et al. Autologous epidermal cultures and narrow-band ultraviolet B in the treatment of vitiligo. Dermatol Surg 2005 31 : 155 9.
118. Pandya V, Parma KS, Shah BJ, Bilimoria FE. A study of autologous melanocyte transfer in treatment of chronic stable vitiligo. Indian J Dermatol Venereol Leprol 2005 71 : 393 7.
119. Chen YF, Yang PY, Hu DN et al. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension - analysis of 120 cases. J Am Acad Dermatol 2004 51 : 68 74.
120. Guerra L, Cappirro S, Melchi F et al. Treatment of stable vitiligo by TimedSurgery and transplantation of cultured epidermal grafts. Arch Dermatol 2000 136 : 1380 9.
121. Guerra L, Primavera G, Raskovic D et al. Erbium YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol 2003 139 : 1303 10.
122. Guerra L, Primavera G, Raskovic D et al. Permanent repigmentation of piebaldism by erbium YAG laser and autologous cultured epidermis. Br J Dermatol 2004 150 : 715 21.
123. Papadopoulos L, Bor R, Legg C. Psychological factors in cutaneous disease; an overview of research. Psychol Health Med 1999 4 : 107 26.
124. Thomson AR, Kent G, Smith JA. Living with vitiligo: dealing with difference. Br J Health Psychol 2002 7 : 213 25.
125. Papadopoulos L, Walker C, Anrhis L. Living with vitiligo: a controlled investigation into the effects of group cognitive-behavioural and person-centred therapies. Dermatol Psychosom 2004 5 : 172 7.